NICE recommends first oral S1P receptor modulator for ulcerative colitis
NICE has recommended the drug Zeposia® (ozanimod) for moderate to severe cases of ulcerative colitis.
List view / Grid view
NICE has recommended the drug Zeposia® (ozanimod) for moderate to severe cases of ulcerative colitis.
NHS England has announced a commercial agreement that allows patients in England immediate access to the innovative new multiple sclerosis treatment...